Insider Moves in Healthcare: Unpacking HIMS Options Trades

Understanding the Recent Options Activity for Hims & Hers Health
High-net-worth investors have recently adopted a bearish outlook on Hims & Hers Health (HIMS), creating ripples in the trading community.
This kind of trading behavior is crucial for retail traders to monitor closely.
We identified notable developments today through comprehensive options activity reports, highlighting significant trades in HIMS options.
While the exact identities of these participants remain unclear, the scale of the activity suggests a strong market sentiment indicating upcoming changes.
This is how we glean insights from their trades.
Today’s options scanner revealed a striking 56 unusual trades for Hims & Hers Health.
This level of activity is decidedly atypical.
The predominant sentiment among these larger traders shows a division: 35% bullish against a noteworthy 50% bearish stance.
The analysis of these trades indicates that 27 were puts, accumulating to a total of $2,889,031, while 29 were calls amounting to $2,337,009.
Potential Price Trajectories for Hims & Hers Health
Examining the trading patterns suggests significant investors are targeting a price range between $20.0 and $95.0 for Hims & Hers Health over the upcoming three months.
Volume and Open Interest DataInsights
Evaluating the volume and open interest serves as a valuable method for understanding the dynamics around a stock.
This information can offer insights into the liquidity and interest in Hims & Hers Health's options reflected across various strike prices.
We review the trends in volume and open interest for calls and puts related to Hims & Hers Health, specifically within a strike price range from $20.0 to $95.0, recorded over the past month.
A Look at Recent Hims & Hers Health Options Trading
The analysis sheds light on significant trades revealed in the market:
Observations on Large Options Trades:
Below are some notable insights from recent Hims options trades:
- Symbol: HIMS | Type: PUT | Trade: Standard | Sentiment: Bearish | Expiration: 02/28/25 | Total Price: $509.8K | Open Interest: 85 | Volume: 558
- Symbol: HIMS | Type: CALL | Trade: Sweep | Sentiment: Bearish | Expiration: 02/28/25 | Total Price: $328.2K | Open Interest: 3.2K | Volume: 2.1K
- Symbol: HIMS | Type: PUT | Trade: Sweep | Sentiment: Bullish | Expiration: 04/17/25 | Total Price: $300.6K | Open Interest: 579 | Volume: 22
- Symbol: HIMS | Type: CALL | Trade: Sweep | Sentiment: Bearish | Expiration: 02/28/25 | Total Price: $272.2K | Open Interest: 1.1K | Volume: 588
- Symbol: HIMS | Type: PUT | Trade: Standard | Sentiment: Bullish | Expiration: 07/18/25 | Total Price: $266.0K | Open Interest: 88 | Volume: 1.3K
Profile of Hims & Hers Health
Hims & Hers Health Inc is recognized as a versatile telehealth platform that bridges consumers with licensed healthcare professionals, facilitating access to high-quality medical care across many areas, including mental health, sexual health, dermatology, and primary care.
A deeper dive into Hims & Hers Health requires us to assess its current market posture and performance metrics.
Current Market Analysis for Hims & Hers Health
- The trading volume is currently at 17,324,900, with the stock price down 8.64% at $62.8.
- Relative Strength Index (RSI) signals suggest the stock may be overbought.
- Upcoming earnings are anticipated to be disclosed in a few days.
Expert Taking on Hims & Hers Health
Analysts have recently weighed in on this stock, yielding a consensus target price of approximately $49.67.
In addition:
- Canaccord Genuity maintains a Buy rating with a target price set at $68.
- Morgan Stanley has downgraded its rating to Equal-Weight, setting a new price target of $60.
- B of A Securities holds an Underperform rating against a target price of $21.
Engaging in options trading carries its fair share of risks, but it does provide opportunities for greater returns. Knowledgeable traders often navigate these risks through continuous learning, strategic adjustments, and by leveraging various market indicators. Stay informed about the most recent options transactions for Hims & Hers Health to seize the right moments in your trading strategy.
Frequently Asked Questions
What type of trading activity occurred for Hims & Hers Health?
Recent options trading showed a significant number of puts and calls, indicating mixed market sentiments.
What is the current stock outlook for Hims & Hers Health?
Experts generally see mixed results, with target prices ranging widely among analysts.
How can traders interpret options activity?
Options activity can signal investor sentiment and potential future price movements.
What role do RSI indicators play in trading analysis?
RSI indicators can indicate whether a stock is overbought or oversold, guiding investment decisions.
What does Hims & Hers Health primarily offer?
As a telehealth platform, it connects consumers to healthcare professionals across various specializations.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.